Blackstone Life Sciences Launches Uniquity Bio with $300M Investment
Key Highlights Uniquity Bio to advance solrikitug, a monoclonal antibody targeting TSLP. $300 million in capital from Blackstone…
Browsing Tag
Nicholas Galakatos
1 post